Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose + H2O
N-acetyl-D-glucosamine + methyl alpha-D-mannose 6-phosphate
-
-
-
?
6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-D-mannose + H2O
N-acetyl-D-glucosamine + D-mannose 6-phosphate
-
-
-
-
?
6-O-(N-acetyl-alpha-D-glucosaminyl)phosphono-D-mannopyranose + H2O
N-acetyl-D-glucosamine + 6-O-phosphono-D-mannopyranose
-
-
-
?
glycoprotein N-acetyl-D-glucosaminyl-phospho-D-mannose + H2O
N-acetyl-D-glucosamine + glycoprotein phospho-D-mannose
methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose + H2O
N-acetyl-D-glucosamine + methyl alpha-D-mannose 6-phosphate
N-acetyl-alpha-D-glucosamine 1-phosphate
N-acetyl-D-glucosamine + phosphate
-
-
-
-
?
N-[6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannosyl]-[alpha-L-iduronidase]-L-asparagine + H2O
N-acetyl-D-glucosamine + N-[6-phospho-alpha-D-mannosyl]-[alpha-L-iduronidase]-L-asparagine
N-[6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannosyl]-[uteroferrin]-L-asparagine + H2O
N-acetyl-D-glucosamine + N-[6-phospho-alpha-D-mannosyl]-[uteroferrin]-L-asparagine
-
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + H2O
N-acetyl-D-glucosamine + UDP
-
-
-
-
?
UDP-N-acetyl-D-glucosamine + H2O
UDP + N-acetyl-D-glucosamine
additional information
?
-
glycoprotein N-acetyl-D-glucosaminyl-phospho-D-mannose + H2O
N-acetyl-D-glucosamine + glycoprotein phospho-D-mannose
-
-
-
?
glycoprotein N-acetyl-D-glucosaminyl-phospho-D-mannose + H2O
N-acetyl-D-glucosamine + glycoprotein phospho-D-mannose
-
removes a covering N-acetylglucosamine from the mannose 6-phosphate recognition marker on lysosomal acid hydrolases
-
?
glycoprotein N-acetyl-D-glucosaminyl-phospho-D-mannose + H2O
N-acetyl-D-glucosamine + glycoprotein phospho-D-mannose
-
removes a covering N-acetylglucosamine from the mannose 6-phosphate recognition marker on lysosomal hydrolases
-
?
glycoprotein N-acetyl-D-glucosaminyl-phospho-D-mannose + H2O
N-acetyl-D-glucosamine + glycoprotein phospho-D-mannose
-
catalyzes a crucial step in lysosomal biogenesis, removes a covering N-acetylglucosamine from the mannose 6-phosphate recognition marker on lysosomal hydrolases
-
?
methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose + H2O
N-acetyl-D-glucosamine + methyl alpha-D-mannose 6-phosphate
-
-
-
-
?
methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose + H2O
N-acetyl-D-glucosamine + methyl alpha-D-mannose 6-phosphate
-
-
-
?
methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose + H2O
N-acetyl-D-glucosamine + methyl alpha-D-mannose 6-phosphate
-
-
-
?
methyl 6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannose + H2O
N-acetyl-D-glucosamine + methyl alpha-D-mannose 6-phosphate
-
low activity
-
-
?
N-[6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannosyl]-[alpha-L-iduronidase]-L-asparagine + H2O
N-acetyl-D-glucosamine + N-[6-phospho-alpha-D-mannosyl]-[alpha-L-iduronidase]-L-asparagine
-
-
-
-
?
N-[6-O-(N-acetyl-alpha-D-glucosaminyl)phospho-alpha-D-mannosyl]-[alpha-L-iduronidase]-L-asparagine + H2O
N-acetyl-D-glucosamine + N-[6-phospho-alpha-D-mannosyl]-[alpha-L-iduronidase]-L-asparagine
-
the enzyme is also active on alpha-L-iduronidase that is recombinantly expressed in transgenic Arabidopsis thaliana seeds
-
-
?
UDP-N-acetyl-D-glucosamine + H2O
UDP + N-acetyl-D-glucosamine
-
-
-
-
?
UDP-N-acetyl-D-glucosamine + H2O
UDP + N-acetyl-D-glucosamine
-
-
-
?
additional information
?
-
-
catalyzes the second step in the formation of the mannose 6-phosphate recognition marker on lysosomal enzyme oligosaccharides
-
?
additional information
?
-
-
removal of the GlcNAc moiety in the trans Golgi network to generate a phosphomonoester, second step of the post-translational modification of lysosomal enzymes with Man-6-P
-
-
?
additional information
?
-
-
D-mannose 6-phosphate phosphodiesters are converted to phosphomonoester
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Alzheimer Disease
PLA2G4A/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophagy and neurodegeneration after brain trauma.
Brain Injuries, Traumatic
PLA2G4A/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophagy and neurodegeneration after brain trauma.
Carcinoma, Hepatocellular
Elevated carbohydrate phosphotransferase activity in human hepatoma and phosphorylation of cathepsin D.
Carcinoma, Hepatocellular
[Carbohydrate phosphotransferase in human hepatoma and phosphorylation of cathepsin D]
Genetic Diseases, Inborn
A model of mucopolysaccharidosis type IIIB in pigs.
Genetic Diseases, Inborn
Molecular defects identified by whole exome sequencing in a child with atypical mucopolysaccharidosis IIIB.
Hydrocephalus
Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain.
Infections
Vitamin D3 activates the autolysosomal degradation function against Helicobacter pylori through the PDIA3 receptor in gastric epithelial cells.
Lysosomal Storage Diseases
Clinical and genetic features of 13 patients with mucopolysaccarhidosis type IIIB: Description of two novel NAGLU gene mutations.
Lysosomal Storage Diseases
Deleting the mouse Hsd17b1 gene results in a hypomorphic Naglu allele and a phenotype mimicking a lysosomal storage disease.
Lysosomal Storage Diseases
Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Mucolipidoses
Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity.
Mucopolysaccharidoses
A mild form of Mucopolysaccharidosis IIIB diagnosed with targeted next-generation sequencing of linked genomic regions.
Mucopolysaccharidoses
A model of mucopolysaccharidosis type IIIB in pigs.
Mucopolysaccharidoses
A novel mutation (c.200T>C) in the NAGLU gene of a Korean patient with mucopolysaccharidosis IIIB.
Mucopolysaccharidoses
A Novel Pathogenic Variant in NAGLU (N-Acetyl-Alpha-Glucosaminidase) gene Identified by Targeted Next-Generation Sequencing Followed by in Silico Analysis.
Mucopolysaccharidoses
A rapid and sensitive method for measuring N-acetylglucosaminidase activity in cultured cells.
Mucopolysaccharidoses
An exonic insertion in the NAGLU gene causing Mucopolysaccharidosis IIIB in Schipperke dogs.
Mucopolysaccharidoses
An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene.
Mucopolysaccharidoses
BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis.
Mucopolysaccharidoses
Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome.
Mucopolysaccharidoses
Clinical and genetic features of 13 patients with mucopolysaccarhidosis type IIIB: Description of two novel NAGLU gene mutations.
Mucopolysaccharidoses
Coinheritance of novel mutations in NAGLU causing mucopolysaccharidosis type IIIB and in DDHD2 causing spastic paraplegia54 in a Turkish family.
Mucopolysaccharidoses
Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.
Mucopolysaccharidoses
Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Mucopolysaccharidoses
Induced pluripotent stem cell line (SDQLCHi041-A) from a male patient with mucopolysaccharidosis type IIIB.
Mucopolysaccharidoses
Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy.
Mucopolysaccharidoses
Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model of Sanfilippo syndrome type B.
Mucopolysaccharidoses
Molecular defects identified by whole exome sequencing in a child with atypical mucopolysaccharidosis IIIB.
Mucopolysaccharidoses
Mucopolysaccharidosis IIIB and mild skeletal anomalies: coexistence of NAGLU and CYP26B1 missense variations in the same patient in a Chinese family.
Mucopolysaccharidoses
Mucopolysaccharidosis type IIIB mutations in Chinese patients: Identification of two novel NAGLU mutations and analysis of two cases involving prenatal diagnosis.
Mucopolysaccharidoses
Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB.
Mucopolysaccharidoses
Significant neuropsychiatric symptoms: three mucopolysaccharidosis type IIIB cases, two of whom were siblings with a novel NAGLU gene mutation.
Mucopolysaccharidoses
Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency.
Mucopolysaccharidoses
Untypically mild phenotype of a patient suffering from Sanfilippo syndrome B with the c.638C>T/c.889C>T (p.Pro213Leu/p.Arg297Ter) mutations in the NAGLU gene.
Mucopolysaccharidosis III
A mild form of Mucopolysaccharidosis IIIB diagnosed with targeted next-generation sequencing of linked genomic regions.
Mucopolysaccharidosis III
A model of mucopolysaccharidosis type IIIB in pigs.
Mucopolysaccharidosis III
A novel mutation in the NAGLU gene associated with Sanfilippo syndrome type B (mucopolysaccharidosis III B).
Mucopolysaccharidosis III
A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design.
Mucopolysaccharidosis III
A rapid and sensitive method for measuring N-acetylglucosaminidase activity in cultured cells.
Mucopolysaccharidosis III
Accelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice.
Mucopolysaccharidosis III
An exonic insertion in the NAGLU gene causing Mucopolysaccharidosis IIIB in Schipperke dogs.
Mucopolysaccharidosis III
An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene.
Mucopolysaccharidosis III
Assessment of predicted enzymatic activity of ?-N-acetylglucosaminidase variants of unknown significance for CAGI 2016.
Mucopolysaccharidosis III
BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis.
Mucopolysaccharidosis III
Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome.
Mucopolysaccharidosis III
Clinical and genetic features of 13 patients with mucopolysaccarhidosis type IIIB: Description of two novel NAGLU gene mutations.
Mucopolysaccharidosis III
Coinheritance of novel mutations in NAGLU causing mucopolysaccharidosis type IIIB and in DDHD2 causing spastic paraplegia54 in a Turkish family.
Mucopolysaccharidosis III
Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB.
Mucopolysaccharidosis III
Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer.
Mucopolysaccharidosis III
Correction of Neurological Disease of Mucopolysaccharidosis IIIB in Adult Mice by rAAV9 Trans-Blood-Brain Barrier Gene Delivery.
Mucopolysaccharidosis III
Differential Uptake of NAGLU-IGF2 and Unmodified NAGLU in Cellular Models of Sanfilippo Syndrome Type B.
Mucopolysaccharidosis III
Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.
Mucopolysaccharidosis III
EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB.
Mucopolysaccharidosis III
Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Mucopolysaccharidosis III
Glycosaminoglycans and mucopolysaccharidosis type III.
Mucopolysaccharidosis III
Identification and characterization of a novel homozygous deletion in the alpha-N-acetylglucosaminidase gene in a patient with Sanfilippo type B syndrome (mucopolysaccharidosis IIIB).
Mucopolysaccharidosis III
Iminosugar C-Glycosides Work as Pharmacological Chaperones of NAGLU, a Glycosidase Involved in MPS IIIB Rare Disease*.
Mucopolysaccharidosis III
Induced pluripotent stem cell line (SDQLCHi041-A) from a male patient with mucopolysaccharidosis type IIIB.
Mucopolysaccharidosis III
Intracranial gene delivery of LV-NAGLU vector corrects neuropathology in murine MPS IIIB.
Mucopolysaccharidosis III
Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B.
Mucopolysaccharidosis III
Molecular analysis of mucopolysaccharidosis type IIIB in Portugal: evidence of a single origin for a common mutation (R234C) in the Iberian Peninsula.
Mucopolysaccharidosis III
Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model of Sanfilippo syndrome type B.
Mucopolysaccharidosis III
Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain.
Mucopolysaccharidosis III
Mucopolysaccharidosis IIIB and mild skeletal anomalies: coexistence of NAGLU and CYP26B1 missense variations in the same patient in a Chinese family.
Mucopolysaccharidosis III
Mucopolysaccharidosis type IIIB mutations in Chinese patients: Identification of two novel NAGLU mutations and analysis of two cases involving prenatal diagnosis.
Mucopolysaccharidosis III
NAGLU mutations underlying Sanfilippo syndrome type B.
Mucopolysaccharidosis III
Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.
Mucopolysaccharidosis III
Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery.
Mucopolysaccharidosis III
Polymorphic variants (p.Ser141Ser and p.Arg737Gly) at the NAGLU gene are really indicative of pseudodeficiency alleles?
Mucopolysaccharidosis III
Residual N-acetyl-?-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB.
Mucopolysaccharidosis III
Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery.
Mucopolysaccharidosis III
Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB.
Mucopolysaccharidosis III
Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B.
Mucopolysaccharidosis III
Sanfilippo type B syndrome: five patients with an R565P homozygous mutation in the alpha-N-acetylglucosaminidase gene from the Okinawa islands in Japan.
Mucopolysaccharidosis III
Significant neuropsychiatric symptoms: three mucopolysaccharidosis type IIIB cases, two of whom were siblings with a novel NAGLU gene mutation.
Mucopolysaccharidosis III
Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice.
Mucopolysaccharidosis III
Structural and mechanistic insight into the basis of mucopolysaccharidosis IIIB.
Mucopolysaccharidosis III
The alpha-N-acetyl-glucosaminidase gene is transcriptionally activated in male and female gametes prior to fertilization and is essential for seed development in Arabidopsis.
Mucopolysaccharidosis III
Treatment of the mouse model of mucopolysaccharidosis type IIIB with lentiviral-NAGLU vector.
Mucopolysaccharidosis III
Untypically mild phenotype of a patient suffering from Sanfilippo syndrome B with the c.638C>T/c.889C>T (p.Pro213Leu/p.Arg297Ter) mutations in the NAGLU gene.
Muscle Hypotonia
A novel frameshift deletion in NAGLU causing sanfilipo type III-B in an Indian family.
Muscle Spasticity
Coinheritance of novel mutations in NAGLU causing mucopolysaccharidosis type IIIB and in DDHD2 causing spastic paraplegia54 in a Turkish family.
n-acetylglucosamine-1-phosphodiester alpha-n-acetylglucosaminidase deficiency
Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.
n-acetylglucosamine-1-phosphodiester alpha-n-acetylglucosaminidase deficiency
Heterozygosity for phosphodiester glycosidase deficiency: a novel human mutation of lysosomal enzyme processing.
n-acetylglucosamine-1-phosphodiester alpha-n-acetylglucosaminidase deficiency
Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model of Sanfilippo syndrome type B.
Neoplasms
Elevated carbohydrate phosphotransferase activity in human hepatoma and phosphorylation of cathepsin D.
Neoplasms
Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial.
Neoplasms
Molecular defects identified by whole exome sequencing in a child with atypical mucopolysaccharidosis IIIB.
Neuroblastoma
Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB.
Neurodegenerative Diseases
BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis.
Neurodegenerative Diseases
Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Neurologic Manifestations
Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery.
Polyneuropathies
Adult-onset painful axonal polyneuropathy caused by a dominant NAGLU mutation.
Stuttering
Analysis of mannose 6-phosphate uncovering enzyme mutations associated with persistent stuttering.
Virus Diseases
Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
C115X
-
site-directed mutagenesis, the mutation greatly impairs folding of the enzyme, the mutant is retained in the endoplasmic reticulum
C132X
-
site-directed mutagenesis, the mutation greatly impairs folding of the enzyme, the mutant is retained in the endoplasmic reticulum
C221L
-
site-directed mutagenesis, the mutation leads to loss of enzymatic activity
C51M
-
site-directed mutagenesis, the mutant shows 65% of wild-type activity
C51M/C221L
-
site-directed mutagenesis, the mutant folds adequately and is trafficked to the Golgi where it is cleaved by furin, the mutant shows only 9.7% of wild-type activity
E502stop
-
similar localization to the trans Golgi network as the wild-type, lumenal domain of UCE was replaced with monomeric GFP
F513S
-
naturally occuring Phe513SerfsX113 frameshift mutation that adds 113 amino acids to the C-terminus of the cytoplasmic tail of the protein including a VWLL sequence, causing rapid degradation via the proteasomal system
H84Q
-
naturally occuring mutation that impairs folding and in addition, decreases the specific activity of the enzyme, to about half the relative specific activity of wild-type enzyme, but folds sufficiently to traffic to the Golgi
M494stop
-
mutant without increased cell surface expression
N137A
-
site-directed mutagenesis, the mutant shows 11% of wild-type activity
N281A
-
site-directed mutagenesis, the mutant is recombinantly expressed but retained in the endoplasmic reticulum
Q225H
-
site-directed mutagenesis, exchange of the human residue for the residue of protein BACOVA_00430 from Bacteroides ovatus, the mutant shows 5.8% of wild-type activity
R247A
-
site-directed mutagenesis, the mutant shows 87% of wild-type activity
R328C
-
naturally occuring mutation that impairs folding in the endoplasmic reticulum, resulting in degradation of a significant portion by the proteasomal system. The mutation leads to lower cellular UCE activity, and might be involved in persistent stuttering phenomena. The R328C mutant forms oligomers with the wild-type enzyme
T227R
-
site-directed mutagenesis, exchange of the human residue for the residue of protein BACOVA_00430 from Bacteroides ovatus, the mutant shows 0.1% of wild-type activity
T320A
-
site-directed mutagenesis, the mutant shows 43% of wild-type activity
V318A
-
site-directed mutagenesis, the mutant is recombinantly expressed but retained in the endoplasmic reticulum
V322A
-
site-directed mutagenesis, the mutant shows 67% of wild-type activity
Y486A
-
mutated residue is required for efficient return of the enzyme from endosomes to the trans-Golgi network, mutant UCE is internalized normally but accumulates on the cell surface, 26-36% of activity on the cell surface compared with 1-3% of wild-type activity, because of increased recycling to the plasma membrane, kinetics of internalization
Y486stop
-
mutant with 16% of total enzyme activity on the cell surface at steady state compared with 1-3% of wild-type activity, kinetics of internalization
Y488A/E493A/E502stop
-
localized to a large extent to the cell surface, lumenal domain of UCE was replaced with monomeric GFP
Y488A/E502stop
-
localized to a large extent to the cell surface, lumenal domain of UCE was replaced with monomeric GFP
Y488A/G496A/E497A/E502stop
-
localized to a large extent to the cell surface, lumenal domain of UCE was replaced with monomeric GFP
Y488A/M494A/E502stop
-
localization shows endosome pattern, not at the cell surface, lumenal domain of UCE was replaced with monomeric GFP
Y488A/M494A/N495A/E502stop
-
intermediate phenotype, localized to the cell surface and to the trans Golgi network, lumenal domain of UCE was replaced with monomeric GFP
Y488A/N495A/E502stop
-
localization shows endosome pattern, not at the cell surface, lumenal domain of UCE was replaced with monomeric GFP
Y488A/P498A/L499A/E502stop
-
localized to a large extent to the cell surface, lumenal domain of UCE was replaced with monomeric GFP
Y488A/Q492A/E493A/E502stop
-
intermediate phenotype, localized to the cell surface and to the trans Golgi network, lumenal domain of UCE was replaced with monomeric GFP
Y488A/Q492A/E493A/M494A/N495A/E502stop
-
localization shows endosome pattern and localized to the Golgi, lumenal domain of UCE was replaced with monomeric GFP
Y488A/Q492A/E502stop
-
similar localization to the trans Golgi network as the wild-type, lumenal domain of UCE was replaced with monomeric GFP
H510stop
-
mutant of the cytosolic tail disrupting the NPF endocytosis motif
H510stop
-
mutant with 7% of total enzyme activity on the cell surface at steady state compared with 1-3% of wild-type activity, kinetics of internalization
Y488A
-
mutant of the cytosolic tail disrupting the tyrosine-based endocytosis motif
Y488A
-
mutant with 63% of total enzyme activity on the cell surface at steady state compared with 1-3% of wild-type activity, kinetics of internalization
Y488A
-
mutation in the 488YHPL internalization signal present in the cytoplasmic tail, mutant UCE accumulates on the cell surface
additional information
-
soluble form lacking residues 1-49, transmembrane and cytoplasmic domains are replaced by the HPC4 epitope
additional information
-
generation of the enzyme in soluble form for conducting the in vitro phosphorylation of purified recombinant lysosomal enzymes
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Kornfeld, R.; Bao, M.; Brewer, K.; Noll, C.; Canfield, W.
Molecular cloning and functional expression of two splice forms of human N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase
J. Biol. Chem.
274
32778-32785
1999
Homo sapiens (Q9UK23), Homo sapiens
brenda
Page, T.; Zhao, K.W.; Tao, l.; Miller, A.L.
Purification and characterization of human lymphoblast N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase
Glycobiology
6
619-626
1996
Homo sapiens
brenda
Lee, J.K.; Pierce, M.
Purification and characterization of human serum N-acetylgluosamine-1-phosphodiester alpha-N-acetylglucosaminidase
Arch. Biochem. Biophys.
319
413-425
1995
Cricetulus griseus, Homo sapiens
brenda
Gheesling Mullis, K.; Huynh, M.; Kornfeld, R.H.
Purification and kinetic parameters of bovine liver N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase
J. Biol. Chem.
269
1718-1726
1994
Bos taurus, Homo sapiens
brenda
Ben-Yoseph, Y.; Potier, M.; Pack, B.A.; Mitchell, D.A.; Melancon, S.B.; Nadler, H.L.
Molecular size of N-acetylglucosaminylphosphotransferase and alpha-N-acetylglucosaminyl phosphodiesterase as determined in situ in Golgi membranes by radiation inactivation
Biochem. J.
235
883-886
1986
Homo sapiens
brenda
Waheed, A.; Hasilik, A.; von Figura, K.
Processing of the phosphorylated recognition marker in lysosomal enzymes. Characterization and partial purification of a microsomal alpha-N-acetylglucosaminyl phosphodiesterase
J. Biol. Chem.
256
5717-5721
1981
Homo sapiens
brenda
Do, H.; Lee, W.S.; Ghosh, P.; Hollowell, T.; Canfield, W.; Kornfeld, S.
Human mannose 6-phosphate-uncovering enzyme is synthesized as a proenzyme that is activated by the endoprotease furin
J. Biol. Chem.
277
29737-29744
2002
Homo sapiens
brenda
Lee, W.S.; Rohrer, J.; Kornfeld, R.; Kornfeld, S.
Multiple signals regulate trafficking of the mannose 6-phosphate-uncovering enzyme
J. Biol. Chem.
277
3544-3551
2002
Homo sapiens
brenda
Rohrer, J.; Kornfeld, R.
Lysosomal hydrolase mannose 6-phosphate uncovering enzyme resides in the trans-Golgi network
Mol. Biol. Cell
12
1623-1631
2001
Homo sapiens
brenda
Wei, Y.; Yen, T.Y.; Cai, J.; Trent, J.O.; Pierce, W.M.; Young, W.W., Jr.
Structural features of the lysosomal hydrolase mannose 6-phosphate uncovering enzyme
Glycoconj. J.
22
13-19
2005
Homo sapiens
brenda
Nair, P.; Schaub, B.E.; Huang, K.; Chen, X.; Murphy, R.F.; Griffith, J.M.; Geuze, H.J.; Rohrer, J.
Characterization of the TGN exit signal of the human mannose 6-phosphate uncovering enzyme
J. Cell Sci.
118
2949-2956
2005
Homo sapiens
brenda
Chavez, C.A.; Bohnsack, R.N.; Kudo, M.; Gotschall, R.R.; Canfield, W.M.; Dahms, N.M.
Domain 5 of the cation-independent mannose 6-phosphate receptor preferentially binds phosphodiesters (mannose 6-phosphate N-acetylglucosamine ester)
Biochemistry
46
12604-12617
2007
Homo sapiens
brenda
Lee, W.S.; Kang, C.; Drayna, D.; Kornfeld, S.
Analysis of mannose 6-phosphate uncovering enzyme mutations associated with persistent stuttering
J. Biol. Chem.
286
39786-39793
2011
Homo sapiens
brenda
Das, D.; Lee, W.S.; Grant, J.C.; Chiu, H.J.; Farr, C.L.; Vance, J.; Klock, H.E.; Knuth, M.W.; Miller, M.D.; Elsliger, M.A.; Deacon, A.M.; Godzik, A.; Lesley, S.A.; Kornfeld, S.; Wilson, I.A.
Structure and function of the DUF2233 domain in bacteria and in the human mannose 6-phosphate uncovering enzyme
J. Biol. Chem.
288
16789-16799
2013
Bacteroides ovatus (A7LRK2), Bacteroides ovatus, Bacteroides ovatus ATCC 8483 (A7LRK2), Homo sapiens
brenda
He, X.; Pierce, O.; Haselhorst, T.; von Itzstein, M.; Kolarich, D.; Packer, N.H.; Gloster, T.M.; Vocadlo, D.J.; Qian, Y.; Brooks, D.; Kermode, A.R.
Characterization and downstream mannose phosphorylation of human recombinant alpha-L-iduronidase produced in Arabidopsis complex glycan-deficient (cgl) seeds
Plant Biotechnol. J.
11
1034-1043
2013
Homo sapiens
brenda